155 related articles for article (PubMed ID: 11931082)
1. Th1/Th2-balance in anterior chamber-associated immune deviation by alloantigen.
Sakai R; Yamagami S; Inoki T; Tsuru T; Kawashima H
Graefes Arch Clin Exp Ophthalmol; 2002 Feb; 240(2):154-9. PubMed ID: 11931082
[TBL] [Abstract][Full Text] [Related]
2. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.
Li XY; D'Orazio LT; Niederkorn JY
Immunology; 1996 Sep; 89(1):34-40. PubMed ID: 8911137
[TBL] [Abstract][Full Text] [Related]
3. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
Kawashima H; Yamagami S; Tsuru T; Gregerson DS
Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
[TBL] [Abstract][Full Text] [Related]
4. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production.
Kosiewicz MM; Alard P; Streilein JW
J Immunol; 1998 Nov; 161(10):5382-90. PubMed ID: 9820512
[TBL] [Abstract][Full Text] [Related]
5. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
D'Orazio TJ; Niederkorn JY
J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
[TBL] [Abstract][Full Text] [Related]
6. Immune privilege in the anterior chamber of the eye is not extended to intraocular Listeria monocytogenes.
Li XY; Niederkorn JY
Ocul Immunol Inflamm; 1997 Dec; 5(4):245-57. PubMed ID: 9455741
[TBL] [Abstract][Full Text] [Related]
7. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
8. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.
Zhang Y; Zhang M; Zhao S; Li X; Jia Z; Zhang L; Han ZC; Zhang X
Int Immunopharmacol; 2013 Jan; 15(1):114-20. PubMed ID: 23178576
[TBL] [Abstract][Full Text] [Related]
9. Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye.
Takahashi M; Ishimaru N; Yanagi K; Saegusa K; Haneji N; Shiota H; Hayashi Y
Clin Exp Immunol; 1999 May; 116(2):231-7. PubMed ID: 10337012
[TBL] [Abstract][Full Text] [Related]
10. Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells.
Paunicka K; Chen PW; Niederkorn JY
J Leukoc Biol; 2012 Mar; 91(3):475-83. PubMed ID: 22180630
[TBL] [Abstract][Full Text] [Related]
11. OVA-specific CD8+ T cells do not express granzyme B during anterior chamber associated immune deviation.
Ren Y; Yang P; Li B; Gao Y; Zhou H; Huang X; Zhu L; Kijlstra A
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1315-21. PubMed ID: 16538449
[TBL] [Abstract][Full Text] [Related]
12. A penetrating ocular injury can affect the induction of anterior chamber-associated immune deviation.
Lei F; Zhang J; Zhang J; He H; Du Y; Yang P
Mol Vis; 2008 Feb; 14():327-33. PubMed ID: 18334954
[TBL] [Abstract][Full Text] [Related]
13. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID).
D'Orazio TJ; Niederkorn JY
Immunology; 1998 Sep; 95(1):47-55. PubMed ID: 9767456
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation.
Chen X; Liu L; Yang P; Wu C; Jin H; Xing L; Li B; Zhou H; Huang X; Zhu L
Immunol Lett; 2006 Nov; 107(2):140-7. PubMed ID: 17055065
[TBL] [Abstract][Full Text] [Related]
15. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
Margenthaler JA; Kataoka M; Flye WM
J Surg Res; 2004 Jun; 119(2):107-12. PubMed ID: 15145690
[TBL] [Abstract][Full Text] [Related]
16. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of peripheral tolerance following intracameral inoculation are independent of IL-13 or STAT6.
Nakamura T; Terajewicz A; Stein-Streilein J
J Immunol; 2005 Aug; 175(4):2643-6. PubMed ID: 16081840
[TBL] [Abstract][Full Text] [Related]
18. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
Skelsey ME; Mellon J; Niederkorn JY
J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
[TBL] [Abstract][Full Text] [Related]
19. Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.
Benson JL; Niederkorn JY
Immunology; 1992 Oct; 77(2):189-95. PubMed ID: 1427974
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
